Purchase Order 75N93024P00667
- Not listed
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $23,491 purchase order to Nanostring Technologies, Inc. of Seattle, Washington. The firm fixed price order is for NANOSTRING CONSUMABLE COSMX/CMX RNA ASSAYS in support of AMBIS 2186472 from September 15, 2023 through December 29, 2023. As a leading provider of advanced tools for biomedical research using its proprietary nCounter Analysis system, Nanostring will deliver its consumable assays to...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a firm fixed price purchase order valued at $15,366 to Nanostring Technologies, Inc. to deliver consumable products supporting genomic analysis on the GeoMx Next Generation Sequencing platform. As a manufacturer of life science tools for translational research and molecular diagnostics, Nanostring will provide RNA biological products and consumables tailored to the agency's biomedical...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $8,813 firm fixed-price purchase order is for the delivery of AMBIS# 1552919NCOUNTER GX CODESET-48 RXNS GXA-P1CS-048, No. 100021. This order is not associated with a set-aside program. Nanostring has...
- This $93,359 firm fixed-price purchase order was awarded to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of Nanostring's proprietary nCounter and GeoMx analysis systems, reagents, and consumables to support genomic, molecular, and cellular...
- Nanostring Technologies, Inc. has been awarded a firm fixed price purchase order valued at $22,941 by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The award has no set-aside designation and work is to be completed by December 31, 2023. As a manufacturer of life science tools for translational research and molecular diagnostics, Nanostring will likely provide specialized equipment, consumables, or services to support genomic and molecular analysis...
- Nanostring Technologies, Inc. has been awarded a firm fixed price purchase order valued at ten thousand two hundred twenty four dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the contract, Nanostring will provide its XT HS HostResponse assay kits and related supplies to support the NIH's infectious disease research efforts. As the prime contractor, Nanostring will deliver four assay kits priced at three thousand three hundred eleven...
- This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $6,895.00 firm fixed price purchase order was awarded on May 11, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for AMBIS# 1554864NCOUNTER GX CODESET--48 RXNS GXA-P1CS-048 (136 GEN X 48 RXNS). This contract has no set-aside designation. Nanostring is the prime...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $14,788 firm fixed price purchase order to Nanostring Technologies, Inc. of Seattle, Washington. Under the contract, Nanostring will provide NANOSTRING REAGENT KITS (AMBIS #2186668) to support NIH/NIAID research efforts. As a leading provider of life science tools for translational research and molecular diagnostic products, Nanostring's reagents will aid...
- Nanostring Technologies, Inc. has been awarded a $12,399 purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide master kits and primers. The products will support research efforts at Nanostring's place of performance in Seattle, Washington through December 2023. A firm fixed price was established for this acquisition of molecular diagnostic tools, with no subcontractors involved. This purchase augments NIH/NIAID's ongoing work...
- This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract, valued at $5,883.00, is a firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) for assay kits. The contract has no set-aside designation. Nanostring has provided a wide range of products and services to various government agencies through past prime and subcontract awards,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $15,366.00 firm fixed-price purchase order contract to Nanostring Technologies, Inc. for the supply of NANOSTRING TECHNOLOGIES INC (AMBIS #2223210) CONSUMABLE XT TAG SETRNA BIOLOGICAL PRODUCTS. This is a non-set-aside contract with an ultimate completion date of August 1, 2024. Nanostring Technologies, Inc. is a publicly traded provider of life science tools and services, including advanced genomic analysis platforms such as the nCounter Analysis Systems and GeoMx Digital Spatial Profiler. The company has a history of providing specialized laboratory equipment, reagents, and testing services to support biomedical research and healthcare programs across various federal agencies, including the USDA and the Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 5/23/24 |